Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Cipta Perdana Lancar Tbk. (PART) Price & Performance

Indofarma Tbk.Trade
Cipta Perdana Lancar Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Cipta Perdana Lancar Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Cipta Perdana Lancar Tbk. trades at Rp102 (market cap 293.61B, 6.37M 24h volume). The key difference: Indofarma Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

INAFPART
Market Cap
390.51B293.61B
Volume
6.37M
Lot
63.66K
Turnover
643.43M
Average Price
101.07
Value
643.43M
Indicative Equilibrium Price
102
Indicative Equilibrium Volume
70

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
PART
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Cipta Perdana Lancar Tbk.

PT. Cipta Perdana Lancar Tbk (the Company) was established based on Notarial Deed No. 02 of Lutfi Burhan, S.H., dated June 5, 2009, Notary in Jakarta. The Company started its commercial operations in June 2009.

Read more on PART